Friday, Jan 9, 2026
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Sport
Science and Tech
Business
Rewind
...
NRI
View Point
cartoon
My Space
Education Today
Reviews
Property
Lifestyle
E-Paper
NRI
View Point
cartoon
My Space
Reviews
Education Today
Property
Lifestyle
"granules-india-limited"
Granules India Limited receives final approval from USFDA for its new drug
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients aged six years and older, as well as for Moderate to Severe Binge Eating Disorder (BED) in adults
Latest News
Scribes demand arrest of Bellampalli MLA Vinod’s aide in Mancherial
7 mins ago
Women stage protest with empty pots at Gram Panchayat office
10 mins ago
GHMC sanitation drive clears abandoned vehicles across 300 wards
14 mins ago
Wyra Lions Club, police distribute study material to Govt. school students
16 mins ago
Why Russia used the Oreshnik hypersonic missile now
18 mins ago
NIT Warangal hosts National Conference on Structural Biophysics
19 mins ago
Zomato’s Deepinder Goyal and Neurologist Dr Sudhir Kumar weigh in on ‘Temple’ wearable in viral X exchange
29 mins ago
‘Golden hour’ reporting key to preventing cybercrime losses: Cyberabad police
36 mins ago
.